The global mammography market is experiencing steady growth, supported by the increasing prevalence of breast cancer, rising awareness of early diagnosis, and the expansion of breast cancer screening programs worldwide. Mammography is a critical medical imaging technique used to detect, diagnose, and monitor breast abnormalities. It plays a significant role in preventive healthcare by enabling the identification of breast cancer at earlier stages, improving the potential for timely treatment.
According to Fortune Business Insights, the global mammography market size was valued at USD 13.86 billion in 2025. The market is projected to grow from USD 14.31 billion in 2026 to USD 19.37 billion by 2034, registering a compound annual growth rate (CAGR) of 3.9% during the forecast period. North America dominated the market, accounting for a 73.09% share in 2025.
Key Market Growth Drivers
Rising Prevalence of Breast Cancer
The increasing incidence of breast cancer worldwide is a major factor supporting the demand for mammography services. Growing patient populations are creating a greater need for screening, diagnostic imaging, and monitoring procedures. Mammography enables healthcare professionals to identify suspicious abnormalities and support further diagnostic evaluation. Increasing emphasis on early detection is expected to contribute to market expansion.
Get a Free Sample PDF - https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/mammography-market-118257
Growing Awareness of Preventive Healthcare
Public awareness campaigns and breast cancer screening initiatives are encouraging women to undergo regular screening examinations. Healthcare organizations and governments are promoting early diagnosis to improve outcomes and reduce the burden associated with advanced-stage disease. Greater awareness of preventive healthcare is strengthening the utilization of mammography services across hospitals, specialty clinics, and diagnostic centers.
Expansion of Screening Programs
National and regional breast cancer screening programs are supporting the adoption of mammography. Organized screening initiatives increase access to diagnostic services and encourage routine examinations among eligible populations. The development of healthcare infrastructure and improved availability of imaging technologies are also contributing to the market's growth.
Emerging Market Trends
Technological advancements are shaping the mammography market. Digital mammography and 3D digital breast tomosynthesis (DBT) are improving image acquisition and visualization. DBT provides multiple breast tissue images from different angles, helping healthcare professionals assess abnormalities more effectively.
Artificial intelligence-assisted image interpretation is another emerging trend. AI-based technologies can support radiologists in analyzing mammography images and identifying suspicious findings. Contrast-enhanced mammography is also gaining attention as healthcare providers seek advanced diagnostic capabilities.
The growing focus on accurate diagnosis, improved imaging efficiency, and technological innovation is expected to influence market developments throughout the forecast period.
Market Segmentation
By Service
The mammography market is segmented into screening mammography services, diagnostic mammography services, and mammography-guided interventional services. Screening mammography services led the market, supported by their widespread use in routine breast cancer screening. Mammography-guided interventional services are projected to grow at a CAGR of 5.9% during the forecast period.
By Imaging Modality
The market includes 2D digital mammography services, 3D digital breast tomosynthesis services, contrast-enhanced mammography services, and other modalities. 3D digital breast tomosynthesis services accounted for a 50.6% market share. Increasing demand for advanced imaging capabilities and improved breast tissue visualization is supporting the adoption of this modality.
By End-User
Based on end-user, the market is categorized into hospitals, specialty clinics, diagnostic centers, and others. Hospitals represent important facilities for mammography services due to their established diagnostic infrastructure and patient volumes. Diagnostic centers and specialty clinics also contribute to market demand by providing dedicated breast imaging services.
Regional Outlook
North America
North America dominated the mammography market, reaching USD 10.13 billion in 2025. The region's leadership is attributed to advanced healthcare infrastructure, favorable reimbursement policies, established screening programs, and widespread adoption of advanced breast imaging technologies. The U.S. remains a major contributor to regional market revenue.
Europe
Europe is projected to grow at a CAGR of 3.9% during the forecast period. The market is expected to reach USD 2.13 billion in 2026. Organized breast cancer screening programs, developed diagnostic infrastructure, and government support for early detection are contributing to regional growth.
Asia Pacific
Asia Pacific is expected to reach USD 1.18 billion in 2026 and remain the third-largest regional market. Rising breast cancer incidence, increasing healthcare expenditure, improvements in diagnostic infrastructure, and greater awareness of early detection are supporting market development.
Latin America and Middle East & Africa
These regions are expected to experience moderate growth. Improving healthcare infrastructure and increasing access to diagnostic imaging services may support the adoption of mammography technologies.
Competitive Landscape
The mammography market features companies focusing on innovation, service expansion, and advanced imaging solutions. Key industry participants identified by Fortune Business Insights include RadNet, Inc., InHealth Group, SimonMed Imaging, Akumin Inc., and Fortis Healthcare Ltd. These companies are emphasizing improved diagnostic accuracy, operational efficiency, and the delivery of advanced mammography services.
Challenges and Opportunities
Market growth may be influenced by the high cost of advanced imaging technologies, disparities in healthcare access, and the need for skilled radiology professionals. Limited diagnostic infrastructure in developing regions can also restrict screening availability.
However, opportunities exist through the expansion of screening programs, investments in healthcare facilities, and the adoption of AI-assisted imaging technologies. Improving awareness and increasing access to preventive diagnostic services may further support market development.
Conclusion
The global mammography market is expected to expand steadily through 2034, driven by increasing breast cancer screening requirements, preventive healthcare awareness, and technological advancements. With the market projected to reach USD 19.37 billion by 2034 at a CAGR of 3.9%, continued development of digital mammography, 3D breast tomosynthesis, and AI-assisted diagnostic solutions is expected to influence the industry's future growth. North America is anticipated to maintain its leading position, while emerging regions may offer opportunities through improved healthcare infrastructure and wider screening access.
Comments